Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Penske Truck Leasing $500 million notes offering
We advised the joint book-running managers on the investment-grade offering
Roche Holdings $1.9 billion notes offering
We advised Roche on the offering comprising three tranches of notes
Tanger $250 million exchangeable senior notes offering
We advised the initial purchasers on the offering
Meitav Investment House NIS 500 million stock offering
We advised Meitav on its global offering
bit.bio $50 million Series C equity financing
We are advising the company on the funding round
MiniMax Group HK$4.8 billion IPO
We advised MiniMax Group on its IPO and HKEX listing
General Motors Financial $1.5 billion senior notes offering
We advised the underwriters on the offering
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Beacon Therapeutics $75 million Series C financing round
We advised Forbion on its participation in the financing round
J.P. Morgan arranges landmark U.S. commercial paper issuance on Solana
We advised J.P. Morgan on structuring the issuance of U.S. commercial paper on a major blockchain